Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4654 (MIR4654) is a short (~22 nucleotide) endogenous non-coding RNA involved in post-transcriptional regulation of gene expression in humans. Like other miRNAs, MIR4654 is transcribed by RNA polymerase II, processed by Drosha and Dicer nucleases, and incorporated into the RNA-induced silencing complex (RISC), enabling it to bind complementary sequences on target mRNAs. This binding commonly results in translational inhibition or mRNA destabilization, contributing to the fine-tuning of protein output and maintaining biological robustness in cellular processes[3][5][6]. While miRNAs broadly are active in diverse cellular functions such as differentiation, proliferation, and apoptosis[1][2], there is currently no published functional or disease-specific data unique to MIR4654. MiRNAs may also participate in nuclear chromatin remodeling, alternative splicing, transcriptional regulation, and cell-cell communication through their extracellular transport[1][4][5][7]. The regulatory role of MIR4654, like other microRNAs, may be broad and context-dependent, but its function remains largely uncharacterized in current literature.
For miRNA-targeting drugs: Inhibition of miRNA function by blocking binding to target mRNAs; miRNA mimics can restore function of downregulated tumor-suppressive miRNAs[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4654 (MIR4654).